This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (122)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Long-term Cosmetic Results

Mary Ann Rose, MD; Ivo Olivotto, MD; Blake Cady, MD; Clinton Koufman, MD; Robert Osteen, MD; Barbara Silver; Abram Recht, MD; Jay R. Harris, MD

Arch Surg. 1989;124(2):153-157.

Abstract
• To evaluate the cosmetic outcome of conservative surgery (CS) and radiation therapy (RT) for early-stage breast cancer and its stability over time, we reviewed the records of 593 patients treated from 1968 to 1981. The breast appearance was scored as "excellent," "good," "fair," or "poor." Median follow-up was 76 months (range, 37 to 186 months). Cosmetic results were generally excellent or good. The percents of excellent, good, fair, and poor results at three years were 65%, 25%, 7%, and 3%, respectively. Patients not receiving adjuvant chemotherapy were more likely than those receiving chemotherapy to have excellent scores at five years (71% vs 40%). Tumor size also influenced cosmetic outcome: 73% of patients with T1 tumors vs 55% with T2 tumors had excellent scores at five years. Our results were stable over time: of 36 patients assessable at seven years whose cosmetic scores were good or excellent at three years, 34 (94%) continued to have good or excellent scores, and only two (5%) deteriorated to fair. We conclude that the cosmetic results achieved with CS and RT are good to excellent in approximately 90% of patients and that these results remain stable for at least seven years.

(Arch Surg 1989;124:153-157)

Author Affiliations
From the Joint Center for Radiation Therapy and Department of Radiation Therapy, Harvard Medical School (Drs Rose, Recht, and Harris and Ms Silver), the Departments of Surgery, New England Deaconess Hospital (Dr Cady), Beth Israel Hospital (Dr Koufman), and Brigham and Women's Hospital (Dr Osteen), Boston; and the Cancer Control Agency of British Columbia (Dr Olivotto), Vancouver, Canada. Dr Rose is now with St Anne's Hospital, Fall River, Mass.

Footnotes
Accepted for publication Nov 7, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 25, 1988.

Reprint requests to St Anne's Hospital, 795 Middle St, Fall River, MA 02721 (Dr Rose).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer
Hughes et al.
NEJM 2004;351:971-977.
ABSTRACT | FULL TEXT  

Cosmetic Outcome in Patients Receiving an Interstitial Implant as Part of Breast-Conservation Therapy
Kramer et al.
Radiology 1999;213:61-66.
ABSTRACT | FULL TEXT  

A 47-Year-Old Woman With Ductal Carcinoma In Situ
Morrow
JAMA 1996;275:61-66.
ABSTRACT